Rothschild Capital Partners, LLC Insulet Corp Transaction History

Rothschild Capital Partners, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$276.36 - $326.03 $1,934 - $2,282	7 Added 0.07%	10,349 $3.3 Million
Q4 2022 Feb 13, 2023	BUY	$212.22 - $313.46 $636 - $940	3 Added 0.03%	10,342 $3.04 Million
Q1 2022 May 04, 2022	SELL	$194.8 - $275.7 $79,283 - $112,209	-407 Reduced 3.79%	10,339 $2.75 Million
Q4 2021 Feb 11, 2022	BUY	$255.32 - $318.29 $88,596 - $110,446	347 Added 3.34%	10,746 $2.86 Million
Q3 2021 Nov 02, 2021	BUY	$260.36 - $307.27 $26,296 - $31,034	101 Added 0.98%	10,399 $2.96 Million
Q2 2021 Jul 30, 2021	SELL	$225.52 - $304.06 $53,899 - $72,670	-239 Reduced 2.27%	10,298 $2.83 Million
Q1 2021 May 03, 2021	SELL	$235.95 - $293.05 $1,179 - $1,465	-5 Reduced 0.05%	10,537 $2.75 Million
Q4 2020 Jan 29, 2021	BUY	$215.97 - $265.89 $64,791 - $79,767	300 Added 2.93%	10,542 $2.7 Million
Q2 2020 Aug 05, 2020	BUY	$159.17 - $224.73 $501,385 - $707,899	3,150 Added 44.42%	10,242 $1.99 Million
Q1 2020 Apr 24, 2020	BUY	$130.01 - $216.44 $922,030 - $1.53 Million	7,092 New	7,092 $1.18 Million

685

62.7M

640K

881K

Ticker PODD
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 69,403,600
Market Cap $18.1B
Description
Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. It offers Omnipod System, a self-adhesive disposable tubeless Omnipod device that is worn on the body for up to three days at a time, as well as its wireless companion, the handheld personal diabetes manager. The company sel...

Get notified when there are updates to the investment portfolio of Rothschild Capital Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Rothschild Capital Partners, LLC with notifications on news.